Ocon Healthcare appoints Dr. Robert Auerbach to Board of Directors
Women’s health company OCON Healthcare has added respected medical leader Dr. Robert Auerbach to its Board of Directors. Dr. Auerbach will bring decades of experience within the femtech industry to help to guide OCON’s strategy, growth and decision making. "We are thrilled to have Dr. Auerbach join our board of directors and provide guidance and leadership to our growing company including USA FDA activities," said OCON CEO Keren Leshem. "Having his experience and background both as a leading FemTech executive and OB/GYN is a great privilege for me personally and a tribute for the company and our board of directors." Dr. Auerbach has more than 36 years of experience in OB/GYN, as well as more than 20 years in the women’s healthcare sector. He is a former President of CooperSurgical Worldwide, the women’s healthcare division of CooperCompanies, and was Associate Clinical Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at the Yale School of Medicine. "With its innovative platform-based technology, OCON is developing products that address some of the most pressing issues facing women", said Dr. Auerbach. "I am very excited to have the opportunity to join the Board of Directors."